HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,283,072 | -3.5% | 344,311 | +3.6% | 0.00% | 0.0% |
| Q2 2023 | $11,693,074 | +30.6% | 332,284 | +21.2% | 0.00% | 0.0% |
| Q1 2023 | $8,954,785 | -40.9% | 274,266 | -0.2% | 0.00% | -33.3% |
| Q4 2022 | $15,144,455 | +27.1% | 274,854 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $11,915,000 | -4.0% | 269,017 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $12,413,000 | +9.4% | 254,530 | +9.2% | 0.00% | +50.0% |
| Q1 2022 | $11,342,000 | +10.4% | 233,134 | -3.2% | 0.00% | 0.0% |
| Q4 2021 | $10,269,000 | +26.2% | 240,824 | +13.4% | 0.00% | +100.0% |
| Q3 2021 | $8,138,000 | +51.6% | 212,308 | +11.7% | 0.00% | 0.0% |
| Q2 2021 | $5,367,000 | +136.1% | 190,121 | +176.4% | 0.00% | – |
| Q1 2021 | $2,273,000 | -15.2% | 68,786 | -7.3% | 0.00% | -100.0% |
| Q4 2020 | $2,682,000 | – | 74,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |